First Edition: Aug. 19, 2021

Post author:Rhiannon Lassiter
Post published:August 19, 2021
Post category:Media

Summaries of health policy coverage from major news organizations
Kaiser Health News

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA
J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech
J&J teams up with Optellum to improve lung cancer survival rates
Optellum collaborating with J&J
Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured. Our vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back.

You Might Also Like

Lung health startup partners with Johnson & Johnson’s lung cancer initiative

Optellum named by the UK government as one of the top 100 digital health companies

Optellum Joins J&J’s Lung Cancer Initiative